Advisor Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$9.47M Buy
17,432
+1,130
+7% +$614K 0.67% 23
2022
Q1
$9.63M Sell
16,302
-537
-3% -$317K 0.6% 27
2021
Q4
$11.2M Sell
16,839
-497
-3% -$332K 0.68% 23
2021
Q3
$9.9M Sell
17,336
-446
-3% -$255K 0.67% 25
2021
Q2
$8.97M Sell
17,782
-235
-1% -$119K 0.59% 29
2021
Q1
$8.22M Sell
18,017
-710
-4% -$324K 0.59% 33
2020
Q4
$8.72M Buy
18,727
+115
+0.6% +$53.6K 0.66% 30
2020
Q3
$8.22M Sell
18,612
-166
-0.9% -$73.3K 0.71% 30
2020
Q2
$6.8M Buy
18,778
+1,300
+7% +$471K 0.63% 33
2020
Q1
$4.96M Buy
17,478
+1,841
+12% +$522K 0.6% 35
2019
Q4
$5.24M Buy
15,637
+897
+6% +$301K 0.54% 37
2019
Q3
$4.29M Buy
14,740
+1,509
+11% +$439K 0.52% 38
2019
Q2
$3.89M Buy
13,231
+564
+4% +$166K 0.47% 42
2019
Q1
$3.47M Sell
12,667
-181
-1% -$49.5K 0.44% 45
2018
Q4
$2.88M Buy
12,848
+1,348
+12% +$302K 0.46% 46
2018
Q3
$2.81M Buy
11,500
+326
+3% +$79.6K 0.38% 50
2018
Q2
$2.32M Buy
11,174
+1,050
+10% +$218K 0.39% 51
2018
Q1
$2.09M Buy
10,124
+839
+9% +$173K 0.39% 55
2017
Q4
$1.98M Buy
9,285
+758
+9% +$162K 0.35% 57
2017
Q3
$1.61M Buy
8,527
+379
+5% +$71.7K 0.32% 64
2017
Q2
$1.42M Buy
8,148
+670
+9% +$117K 0.33% 71
2017
Q1
$1.15M Sell
7,478
-34
-0.5% -$5.22K 0.31% 80
2016
Q4
$1.06M Buy
7,512
+141
+2% +$19.9K 0.32% 80
2016
Q3
$1.17M Buy
7,371
+1,209
+20% +$192K 0.39% 64
2016
Q2
$911K Buy
6,162
+125
+2% +$18.5K 0.32% 82
2016
Q1
$855K Buy
6,037
+2,089
+53% +$296K 0.32% 88
2015
Q4
$560K Buy
3,948
+39
+1% +$5.53K 0.19% 136
2015
Q3
$478K Sell
3,909
-1,704
-30% -$208K 0.2% 130
2015
Q2
$750K Buy
5,613
+983
+21% +$131K 0.29% 104
2015
Q1
$622K Buy
4,630
+557
+14% +$74.8K 0.26% 108
2014
Q4
$510K Sell
4,073
-1
-0% -$125 0.23% 129
2014
Q3
$496K Buy
4,074
+24
+0.6% +$2.92K 0.28% 101
2014
Q2
$478K Buy
4,050
+102
+3% +$12K 0.24% 127
2014
Q1
$475K Buy
3,948
+69
+2% +$8.3K 0.26% 121
2013
Q4
$432K Buy
3,879
+226
+6% +$25.2K 0.25% 129
2013
Q3
$337K Buy
3,653
+146
+4% +$13.5K 0.24% 135
2013
Q2
$297K Buy
+3,507
New +$297K 0.24% 134